Honz Pharmaceutical Co., Ltd. (SHE:300086)

Honz Pharmaceutical Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Total Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 9, 2026	Dec 31, 2025	Jan 1, 2025	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022
Market Capitalization	3,054	5,475	2,230	2,642	2,799	3,906
Market Cap Growth	0.60%	145.51%	-15.57%	-5.63%	-28.34%	54.45%
Enterprise Value	3,485	5,967	2,676	3,033	3,196	4,251
Last Close Price	6.71	12.03	4.90	5.87	6.22	8.68

Price Ratios

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 9, 2026	Dec 31, 2025	Jan 1, 2025	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022
PE Ratio	-	-	-	229.10	-	355.50
Forward PE	-	36.32	36.32	36.32	36.32	36.32
PS Ratio	8.07	11.75	4.75	3.57	5.22	4.67
PB Ratio	3.44	5.94	1.96	1.92	2.07	2.51
P/TBV Ratio	3.82	6.62	2.32	2.27	2.48	3.05
P/FCF Ratio	120.33	188.01	-	-	-	-
P/OCF Ratio	69.97	45.16	31.21	37.37	95.45	344.77

EV Ratios

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 9, 2026	Dec 31, 2025	Jan 1, 2025	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022
EV/Sales Ratio	9.20	12.80	5.70	4.10	5.97	5.08
EV/EBITDA Ratio	-	-	-	22.93	-	126.48
EV/EBIT Ratio	-	-	-	55.30	-	-
EV/FCF Ratio	137.31	204.91	-	-	-	-

Financial Efficiency

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 9, 2026	Dec 31, 2025	Jan 1, 2025	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022
Debt / Equity Ratio	0.48	0.49	0.45	0.36	0.43	0.38
Debt / EBITDA Ratio	-	-	-	3.79	-	15.09
Debt / FCF Ratio	16.80	15.34	-	-	-	-
Net Debt / Equity Ratio	0.46	0.42	0.35	0.26	0.23	0.22
Net Debt / EBITDA Ratio	-6.25	-4.05	-4.64	2.70	-3.25	9.93
Net Debt / FCF Ratio	16.16	13.29	-18.89	-5.33	-10.58	-1.60
Asset Turnover	0.21	0.25	0.23	0.33	0.23	0.33
Inventory Turnover	1.07	1.27	1.06	1.47	1.46	2.05
Quick Ratio	0.10	0.19	0.40	0.85	0.79	0.99
Current Ratio	0.46	0.52	0.85	1.60	1.33	1.49
Return on Equity (ROE)	-21.27%	-22.70%	-17.76%	0.38%	-13.61%	0.67%
Return on Assets (ROA)	-4.30%	-5.36%	-4.49%	1.54%	-3.86%	-0.13%
Return on Invested Capital (ROIC)	-9.49%	-11.35%	-9.10%	0.71%	-8.25%	-0.14%
Return on Capital Employed (ROCE)	-10.90%	-13.40%	-10.20%	3.10%	-8.20%	-0.30%

Yields

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 9, 2026	Dec 31, 2025	Jan 1, 2025	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022
Earnings Yield	-6.84%	-4.20%	-9.66%	0.44%	-6.70%	0.28%
FCF Yield	0.83%	0.53%	-0.94%	-2.53%	-1.06%	-5.34%
Payout Ratio	-	-	-	211.14%	-	370.22%
Buyback Yield / Dilution	-0.25%	-0.84%	-0.20%	-0.10%	0.08%	-0.29%
Total Shareholder Return	-0.25%	-0.84%	-0.20%	-0.10%	0.08%	-0.29%

Data Source: S&P Global Market Intelligence Last updated: Aug 26, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 10, 2026

Data Sources Report a data error